Molecular Pharmacology: 27 (3)

March 01, 1985; Volume 27,Issue 3

You have access
Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
S B Masters, M T Quinn and J H Brown

Molecular Pharmacology March 1985, 27 (3) 325-332;
You have access
Effects of nitroprusside, glyceryl trinitrate, and 8-bromo cyclic GMP on phosphorylase a formation and myosin light chain phosphorylation in rat aorta.
R M Johnson and T M Lincoln

Molecular Pharmacology March 1985, 27 (3) 333-342;
You have access
Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
S M Sherby, A T Eldefrawi, E X Albuquerque and M E Eldefrawi

Molecular Pharmacology March 1985, 27 (3) 343-348;
You have access
Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
M B Cohen and R I Glazer

Molecular Pharmacology March 1985, 27 (3) 349-355;
You have access
Thiol-dependent DNA damage produced by anthracycline-iron complexes. The structure-activity relationships and molecular mechanisms.
J Muindi, B K Sinha, L Gianni and C Myers

Molecular Pharmacology March 1985, 27 (3) 356-365;
You have access
Mechanism of action of diabetogenic zinc-chelating agents. Model system studies.
R M Epand, A R Stafford, M Tyers and E Nieboer

Molecular Pharmacology March 1985, 27 (3) 366-374;
You have access
Metabolic activation and toxicity of acetaminophen and related analogs. A theoretical study.
G H Loew and A Goldblum

Molecular Pharmacology March 1985, 27 (3) 375-386;
You have access
Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
J S Lazo, W N Hait, K A Kennedy, I D Braun and B Meandzija

Molecular Pharmacology March 1985, 27 (3) 387-393;
You have access
Phenobarbital induces rat liver apolipoprotein A-I mRNA.
Y S Chao, C B Pickett, T T Yamin, L S Guo, A W Alberts and P A Kroon

Molecular Pharmacology March 1985, 27 (3) 394-398;
You have access
A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site.
R B Rothman, W D Bowen, M Herkenham, A E Jacobson, K C Rice and C B Pert

Molecular Pharmacology March 1985, 27 (3) 399-409;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals